Patents by Inventor Steffen Walter

Steffen Walter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER
    Publication number: 20170304399
    Abstract: A pharmaceutical composition contains an antibody or a fragment thereof specific for COL6A3 for the treatment of a cancer. A method of treating a cancer includes administering to a subject in need thereof the pharmaceutical composition. A kit includes a container that contains the pharmaceutical composition. A method of producing an antibody or a fragment thereof against a peptide or a MHC/peptide complex. A method for detecting a diseased tissue includes administering to a subject in need thereof an antibody or a fragment thereof conjugated to a radioisotope and detecting a signal from the radioisotope in the subject. A method for treating a diseased tissue includes administering to a subject in need thereof an antibody or a fragment thereof conjugated to a toxin.
    Type: Application
    Filed: June 28, 2017
    Publication date: October 26, 2017
    Inventors: Jens FRITSCHE, Toni Weinschenk, Steffen Walter, Peter Lewandrowski, Harpreet Singh
  • Immunotherapy against several tumors including gastrointestinal and gastric cancer
    Patent number: 9717774
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 95 novel peptide sequences and their variants derived from HLA class I molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: August 1, 2017
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Jens Fritsche, Toni Weinschenk, Steffen Walter, Peter Lewandrowski, Harpreet Singh
  • NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC
    Publication number: 20170202937
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to more than 70 novel peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: November 21, 2016
    Publication date: July 20, 2017
    Inventors: Toni WEINSCHENK, Steffen WALTER, Jens FRITSCHE, Colette Song, Harpreet SINGH
  • NOVEL T CELL RECEPTORS ANDIMMUNE THERAPY USING THE SAME
    Publication number: 20170055531
    Abstract: The present invention relates to novel compositions comprising certain pyrazolecarboxylic acid alkoxyamides according to formula (I) in combination with certain fungicides, to a process for preparing these compositions and to the use thereof as biologically active compositions, especially for the control of harmful microorganisms in plants and in the protection of materials and as plant growth regulators.
    Type: Application
    Filed: February 17, 2015
    Publication date: March 2, 2017
    Applicant: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Leonie ALTEN, Dominik MAURER, Steffen WALTER, Sebastian BUNK
  • NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
    Publication number: 20160376316
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: August 2, 2016
    Publication date: December 29, 2016
    Inventors: Toni WEINSCHENK, Oliver SCHOOR, Claudia TRAUTWEIN, Norbert HILF, Steffen WALTER, Harpreet SINGH
  • NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
    Publication number: 20160376313
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: August 2, 2016
    Publication date: December 29, 2016
    Inventors: Toni WEINSCHENK, Oliver SCHOOR, Claudia TRAUTWEIN, Norbert HILF, Steffen WALTER, Harpreet SINGH
  • NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
    Publication number: 20160376315
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: August 2, 2016
    Publication date: December 29, 2016
    Inventors: Toni WEINSCHENK, Oliver SCHOOR, Claudia TRAUTWEIN, Norbert HILF, Steffen WALTER, Harpreet SINGH
  • NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
    Publication number: 20160376317
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: August 2, 2016
    Publication date: December 29, 2016
    Inventors: Toni WEINSCHENK, Oliver SCHOOR, Claudia TRAUTWEIN, Norbert HILF, Steffen WALTER, Harpreet SINGH
  • NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
    Publication number: 20160376312
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: August 2, 2016
    Publication date: December 29, 2016
    Inventors: Toni WEINSCHENK, Oliver SCHOOR, Claudia TRAUTWEIN, Norbert HILF, Steffen WALTER, Harpreet SINGH
  • NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
    Publication number: 20160376314
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: August 2, 2016
    Publication date: December 29, 2016
    Inventors: Toni WEINSCHENK, Oliver SCHOOR, Claudia TRAUTWEIN, Norbert HILF, Steffen WALTER, Harpreet SINGH
  • NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
    Publication number: 20160355550
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: August 2, 2016
    Publication date: December 8, 2016
    Inventors: Toni WEINSCHENK, Oliver SCHOOR, Claudia TRAUTWEIN, Norbert HILF, Steffen WALTER, Harpreet SINGH
  • Immunogenic epitopes for immunotherapy
    Patent number: 9511128
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. The present invention relates to novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells which can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: December 6, 2016
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Harpreet Singh, Steffen Walter, Toni Weinschenk, Norbert Hilf, Oliver Schoor, Claudia Trautwein
  • Rotary anode and method for producing a base body for a rotary anode
    Patent number: 9512040
    Abstract: A rotary anode for an X-ray tube includes a ceramic base body that carries a focal path for emitting X-rays during electron irradiation. The ceramic base body is made of a mixture of silicon carbide and at least one high temperature-resistant diboride.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: December 6, 2016
    Assignee: Siemens Aktiengesellschaft
    Inventors: Joerg Freudenberger, Stefan Lampenscherf, Gia Khanh Pham, Steffen Walter
  • Method for Producing a Capacitor, Capacitor and Use Thereof
    Publication number: 20160336113
    Abstract: A capacitor, a method for producing a capacitor, and the use of a capacitor of for producing an electric cable, a coaxial cable and/or a resonant heating cable are disclosed. The method may be suitable for mass production of a capacitor, e.g., a cylindrical capacitor. The method may include alternately coating a main member with dielectric and electrically conducting layers using thermal spraying and/or spraying, and then sintering the resulting structure. The resulting capacitor may provide advantageous design variability, e.g., with respect to the capacitance and breakdown voltage, as well as excellent temperature resistance.
    Type: Application
    Filed: December 9, 2014
    Publication date: November 17, 2016
    Applicant: Siemens Aktiengesellschaft
    Inventors: Richard Matz, Steffen Walter
  • Scanner device
    Patent number: 9389417
    Abstract: The invention relates to a scanner device having a mirror arranged so as to be pivotable about an axis of rotation, an iron core with an air gap, a coil arranged about a portion of the iron core, and two permanent magnets. The two magnets have differently directed magnetizations and are arranged inside the air gap at different angular rotation positions with respect to the axis of rotation. An armature made of a soft-magnetic material is arranged on the mirror in such a manner that the armature is residing inside the air gap and, by means of application of electric current to the coil, the armature is moved toward one of the two magnets, depending on the direction of the current, and the mirror rotates.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: July 12, 2016
    Assignee: Scansonic MI GmbH
    Inventors: Steffen Walter, André Lange
  • NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS
    Publication number: 20160175357
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 11 novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: September 25, 2015
    Publication date: June 23, 2016
    Inventors: Toni WEINSCHENK, Oliver SCHOOR, Claudia TRAUTWEIN, Norbert HILF, Steffen WALTER, Harpreet SINGH
  • IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC
    Publication number: 20160168200
    Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to more than 70 novel peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
    Type: Application
    Filed: August 4, 2014
    Publication date: June 16, 2016
    Applicant: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Toni WEINSCHENK, Steffen WALTER, Jens FRITSCHE, Colette SONG, Harpreet SINGH
  • USE OF SPARK PLASMA SINTERING FOR MANUFACTURING SUPERALLOY COMPOUND COMPONENTS
    Publication number: 20160158840
    Abstract: A method of manufacturing a superalloy compound component is provided. The component includes a first component portion primarily consisting of a first superalloy and a second component portion primarily consisting of a second superalloy or of a refractory metal. The method includes using Spark Plasma Sintering for forming the superalloy compound component.
    Type: Application
    Filed: November 25, 2013
    Publication date: June 9, 2016
    Inventors: Marco Cologna, Anand A. Kulkarni, Stefan Lampenscherf, Gia Khanh Pham, Cora Schillig, Steffen Walter
  • Combination therapy using active immunotherapy
    Patent number: 9308244
    Abstract: The present invention relates to methods of treating cancer in a mammal comprising administering to the mammal a combination therapy comprising a vaccine and a multi-kinase inhibitor, wherein the vaccine comprises an isolated tumor associated peptide having the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I or class-II. Preferably the multi-kinase inhibitor is sunitinib malate and/or sorafenib tosylate or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: April 12, 2016
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Harpreet Singh, Niels Emmerich, Nobert Hilf, Steffen Walter, Toni Weinschenk
  • Scanner Device
    Publication number: 20160077331
    Abstract: The invention relates to a scanner device having a mirror arranged so as to be pivotable about an axis of rotation, an iron core with an air gap, a coil arranged about a portion of the iron core, and two permanent magnets. The two magnets have differently directed magnetizations and are arranged inside the air gap at different angular rotation positions with respect to the axis of rotation. An armature made of a soft-magnetic material is arranged on the mirror in such a manner that the armature is residing inside the air gap and, by means of application of electric current to the coil, the armature is moved toward one of the two magnets, depending on the direction of the current, and the mirror rotates.
    Type: Application
    Filed: April 14, 2014
    Publication date: March 17, 2016
    Inventors: Steffen Walter, André Lange